Identification of human cancers deficient in antigen processing
about
Cellular distribution of proteasome subunit Lmp7 mRNA and protein in human placentasNatural selection of tumor variants in the generation of "tumor escape" phenotypesNormal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1Antigen processing in vivo and the elicitation of primary CTL responsesCytotoxic T cell immunity against telomerase reverse transcriptase in humansSynthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTLOverexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cellsGene therapy for carcinoma of the breast: Genetic immunotherapyLicensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral ControlMyeloid suppressor cells and immune modulation in lung cancerTumour immunology, vaccination and escape strategiesThe transporter associated with antigen processing: function and implications in human diseasesCCL21 Chemokine Therapy for Lung Cancer.Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cellsMyeloid suppressor cell depletion augments antitumor activity in lung cancerMelanoma Peptide Vaccines.Novel insights into the molecular mechanisms of HLA class I abnormalities.Identification of E2F1 as an important transcription factor for the regulation of tapasin expression.Prostate cancer immunotherapy at the dawn of the new millennium.Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.Response to influenza infection in mice with a targeted disruption in the interferon gamma geneTumor antigens and tumor vaccines: peptides as immunogens.SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.Increased proteolysis of diphtheria toxin by human monocytes after heat shock: a subsidiary role for heat-shock protein 70 in antigen processing.Targeting p53 as a general tumor antigen.Activation of the immune system in cancer patients.Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery.T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell.An overview of cancer immunotherapy.Immune selection in neoplasia: towards a microevolutionary model of cancer development.Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker.Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer.Assumptions of the tumor 'escape' hypothesis.
P2860
Q24541452-EA5D148B-A1DC-45B3-A6C0-FF4BDFC3BB0EQ24551158-8FC67508-1A95-4844-B4FE-805C1D540CA7Q24648492-4FBE09F4-5313-45EA-B448-D347AE9DAFF5Q24675502-F2204135-71D0-4CF0-8857-1DAC2897B3DEQ24676613-5602ACD5-960D-425F-A04A-93CBC108C335Q24684276-DF8B1F33-74D7-4616-85F8-E26D977E2BF0Q24793668-4A083A35-9FDA-48DD-8685-5327B5409DB7Q24797848-A7E83BC7-2520-455E-93B4-3FA73085C37CQ26747397-E956FAE7-266C-4654-8334-4F8CEBF41F51Q26823251-86AF58D3-8DB6-424A-AB84-2094E7D1918CQ28208633-FCF8D785-6ADE-4BF9-BC39-C49FBBC292C4Q28214433-622FDA22-1D91-4D88-86B6-C1AFF7BA6EBBQ28248811-F285BDA5-219A-4ED9-B78A-8CC2FC101606Q28295513-B9997207-6DDC-444E-ABB9-E3C13139019CQ28729158-D3642233-3C2D-4B01-8966-86E65104214DQ30305778-9EFDC519-01C8-4602-A36E-26B3C0BC5427Q30318252-D6459959-B517-40B2-9BAA-D1EE43AD569DQ30318613-79E9B44B-86C1-4B76-9DEE-C97584EADC62Q30327421-0ECD3C46-4517-4A12-BBD7-E94765DB73DAQ30426606-F2F37294-1C5D-406E-A02B-5802BBDD3CEBQ30442876-817A05DE-B87F-453B-B0AF-2442485761A1Q30469630-763F3639-D05D-4144-AB57-0AB1D31CCC84Q30536340-40D8A8B9-49D8-41A8-B8DC-B4994BDC8A35Q33264116-84962464-B98A-4564-90F2-0832D16AA5F6Q33638172-386340AD-DD48-43DB-BDAA-AE346551F2A3Q33803922-1EA0432A-76CE-4D02-B455-9326D4113F2AQ33805562-EB526DEC-921D-4B45-B602-5A0A5C459977Q33827463-512CAE75-E057-475C-9D71-6B259481FCFAQ33894691-88E9B4EC-32CB-4C59-9F0F-4BA9101F36DBQ33935247-955580FF-D9C2-4E7C-8295-FB35C43053BCQ33940388-72BB6F1E-92D6-4623-B25C-438895A4D934Q33948688-FCD48237-BC0D-40B9-B007-453DCE099E30Q34035564-19DB1D8E-5F00-4020-BB1B-8580CE7C264FQ34126942-FD54A7CE-5D47-429B-A678-CAE455414EFEQ34169329-55BF881C-C653-435A-8BCD-6D56A9BA3959Q34207168-753F8F4C-4C93-42CD-9FE3-E5DCC57F3707Q34208784-6ED119FE-7C0D-4AC6-8235-677F47520B00Q34452013-41BD80F3-1500-47DD-AD26-9480763DE055Q34452039-C229267C-557D-47BD-993D-FD4286470D89Q34583258-4CE750ED-DAF3-4959-9951-58980E01273C
P2860
Identification of human cancers deficient in antigen processing
description
1993 nî lūn-bûn
@nan
1993 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Identification of human cancers deficient in antigen processing
@ast
Identification of human cancers deficient in antigen processing
@en
Identification of human cancers deficient in antigen processing
@nl
type
label
Identification of human cancers deficient in antigen processing
@ast
Identification of human cancers deficient in antigen processing
@en
Identification of human cancers deficient in antigen processing
@nl
prefLabel
Identification of human cancers deficient in antigen processing
@ast
Identification of human cancers deficient in antigen processing
@en
Identification of human cancers deficient in antigen processing
@nl
P2093
P2860
P3181
P356
P1476
Identification of human cancers deficient in antigen processing
@en
P2093
J R Bennink
J W Yewdell
N P Restifo
S A Rosenberg
Y Kawakami
P2860
P304
P3181
P356
10.1084/JEM.177.2.265
P407
P50
P577
1993-02-01T00:00:00Z